SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001193125-17-089334
Filing Date
2017-03-20
Accepted
2017-03-20 16:11:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B2 d357387d424b2.htm 424B2 260670
2 GRAPHIC g357387g14l32.jpg GRAPHIC 45879
3 GRAPHIC g357387g36x35.jpg GRAPHIC 51983
  Complete submission text file 0001193125-17-089334.txt   396561
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-214721 | Film No.: 17701531
SIC: 2836 Biological Products, (No Diagnostic Substances)